Mechanism of action of orlistat
Medically reviewed on Jan 1, Xenical is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. Xenical is also indicated to reduce mechanism of action of orlistat risk for weight regain after prior weight loss.

orlistat action of mechanism of
Medically reviewed on Jan 1, Xenical is indicated for obesity management including "orlistat" loss and weight maintenance when used in conjunction with a reduced-calorie diet. Xenical is also indicated to reduce the risk for weight regain mechanism action prior weight loss. Table 1 illustrates body mass index BMI according to "orlistat" variety of weights and heights. The BMI is orlistat by dividing weight in kilograms by height in meters squared.
For example, a person who weighs lbs and is 5 ' 5 " would have a BMI of The recommended dose of Xenical is one mg capsule three times a day with each main meal containing fat during or up to 1 hour after the meal. The daily intake of fat, carbohydrate, and protein should be distributed over three main meals. If a meal is occasionally weaning off ambien side effects or contains no fat, the dose of Xenical can be omitted.
Because Xenical has been shown to reduce the absorption of some how to make a xanax high better orlistat and beta-carotene, patients should be counseled to take a multivitamin containing fat-soluble vitamins to ensure adequate nutrition [see Warnings and Precautions 5.
The vitamin supplement should be taken at least 2 hours before or after orlistat of of mechanism action administration of Xenical, such mechanism at bedtime. For patients receiving both Xenical and cyclosporine therapy, administer cyclosporine 3 hours after Xenical. For patients receiving both Xenical and levothyroxine therapy, administer levothyroxine and Xenical at least 4 hours apart.
Patients treated concomitantly with Xenical and levothyroxine should be monitored for changes in thyroid function. Based on fecal fat measurements, the effect of Xenical is seen as soon as 24 to 48 hours after dosing. Upon discontinuation of therapy, fecal fat content usually returns to pretreatment levels within 48 to 72 hours. Therefore, Xenical and cyclosporine should not be simultaneously coadministered.
To reduce the chance of a drug-drug interaction, cyclosporine should be taken at least 3 hours before or after Xenical in patients taking both drugs. In addition, in those patients whose cyclosporine levels are being measured, more frequent monitoring should be considered. In addition, the levels of vitamin D and beta-carotene may be low in obese patients compared with non-obese subjects. The supplement should be taken once a day at orlistat 2 hours before or after the administration of Xenical, such as at bedtime.
A reduction in dose of oral hypoglycemic medication e. There have been rare postmarketing reports of severe liver injury with hepatocellular necrosis or acute hepatic failure in patients treated with Xenical, with some of these cases resulting in liver transplant or death. Patients should be instructed to report any symptoms of hepatic dysfunction anorexia, pruritus, jaundice, dark urine, light-colored stools, or right upper quadrant pain while taking Orlistat. When these symptoms occur, Xenical and other suspect medications should be discontinued immediately and liver function tests and ALT and AST levels obtained.
Some patients may develop increased levels of urinary oxalate following treatment with Xenical. Cases of oxalate nephrolithiasis and oxalate nephropathy with renal failure have orlistat reported. Monitor renal function when prescribing Xenical to patients at risk for renal impairment and use with caution in those with a history of hyperoxaluria or calcium oxalate nephrolithiasis.
Substantial weight loss can increase the risk of cholelithiasis. In orlistat clinical trial of Xenical for the prevention of type 2 diabetes, the rates of cholelithiasis as an adverse event were 2. Organic causes of obesity e. Patients should be advised to adhere to dietary guidelines [see Dosage and Administration 2 ]. Gastrointestinal events [see Adverse Reactions 6. The daily intake of fat should be distributed over three main meals.
If Xenical is taken with any one meal very high in fat, the possibility of gastrointestinal effects increases. Because clinical trials are conducted under widely varying conditions, adverse reaction orlistat action observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug xanax bars yellow green may not reflect the rates observed in patients.
Commonly Observed based on first year action second year data. Gastrointestinal GI symptoms were the most commonly observed treatment-emergent adverse events valium and muscle spasm with the use of Xenical in the seven double-blind, placebo-controlled clinical trials and are primarily a manifestation of the mechanism of action.
In general, the first occurrence of these events was within 3 months of starting therapy. However, GI adverse events may occur in some individuals over a period of 6 months or longer. In controlled clinical trials, 8. For St john s wort and wellbutrin interactions, the most common adverse orlistat resulting in discontinuation of treatment were gastrointestinal.
Table 4 illustrates the percentage of adult patients on Do i have to take adderall every day and placebo who orlistat a low vitamin level on two or more consecutive visits during 1 and 2 years of therapy in studies in which patients were not previously receiving orlistat supplementation.
Table 5 illustrates the percentage of adolescent patients on Xenical and placebo who developed a low vitamin level on two or more consecutive propecia side effects likelihood during the 1-year study. In the 4-year XENDOS study, the general pattern of adverse events was similar to that reported for the 1- and 2-year studies with the total incidence of gastrointestinal-related adverse events occurring in year 1 decreasing each year over the 4-year period.
In clinical trials in obese diabetic patients, hypoglycemia and abdominal distension were also observed. In clinical trials with Xenical in adolescent patients ages 12 to 16 years, the profile of adverse reactions was generally similar to that observed in adults. The following adverse reactions have been identified during postapproval use of Xenical. Because these "action" are orlistat voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to Xenical exposure.
Data from a Xenical and cyclosporine drug interaction study tramadol get out of your system a reduction in cyclosporine plasma levels when Xenical was coadministered with cyclosporine. Xenical and cyclosporine should not be simultaneously coadministered. Cyclosporine should be administered 3 hours after the administration of Xenical [see Dosage and Administration 2and Warnings and Precautions 5.
Data from a pharmacokinetic interaction study showed that the absorption of beta-carotene supplement is reduced when concomitantly administered with Xenical. Xenical inhibited absorption of a vitamin E acetate supplement. The effect of Xenical on the absorption of supplemental vitamin D, vitamin A, and orlistat vitamin K is not known at this time [see Clinical Pharmacology Hypothyroidism has been reported in patients treated concomitantly with Xenical and levothyroxine postmarketing.
Administer levothyroxine and Xenical at least 4 hours orlistat [see Dosage and Administration 2 ]. Vitamin K absorption may be decreased with Xenical. Reports of decreased prothrombin, increased INR and unbalanced anticoagulant treatment resulting in change of hemostatic parameters have been reported orlistat patients treated concomitantly with Xenical and anticoagulants. Patients on chronic stable doses of warfarin or other anticoagulants who are prescribed Xenical should be monitored closely for changes in coagulation parameters [see Clinical Pharmacology A pharmacokinetic study, where amiodarone was orally administered during orlistat treatment, demonstrated a reduction in orlistat to amiodarone and its does tramadol test as a opiate or narcotics, desethylamiodarone [see Clinical Pharmocology A reduced therapeutic effect of amiodarone is possible.
The effect of commencing orlistat treatment in patients on stable amiodarone therapy has not been studied. Convulsions have been reported in patients treated concomitantly with orlistat and antiepileptic drugs. The exact mechanism for this is unclear, but may include a drug-drug interaction that inhibits systemic absorption of the antiretroviral drug. If there is a confirmed increase in HIV viral load, Xenical should be discontinued.
Xenical is contraindicated during pregnancy, because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm. A orlistat weight gain, and no mechanism loss, is currently recommended for all pregnant women, including those who are already overweight or obese, due to the obligatory weight gain that occurs in maternal tissues during pregnancy. No embryotoxicity or teratogenicity was seen in animals that received orlistat at doses much higher than the recommended human dose.
If this drug is used orlistat pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard of maternal weight loss to orlistat fetus. Neither study showed embryotoxicity or teratogenicity. It is not known if Xenical is present in human milk. Caution should be exercised when Xenical is administered to a nursing woman.
Safety and effectiveness in pediatric patients below the age of 12 have not been established. The safety and efficacy of Xenical have been evaluated in obese adolescent patients aged 12 to 16 years. Use of Xenical in this age group is supported by evidence from adequate and well-controlled studies of Xenical in adults with additional data from a week efficacy and safety study and a day mineral balance study in obese adolescent patients aged 12 to 16 years.
Patients treated with Xenical in the week efficacy and safety study In a subgroup of Xenical and 77 placebo patients from the week study, changes in body composition measured by DEXA were similar in both treatment groups with the exception of fat mass, which was significantly reduced in patients treated with Xenical orlistat to patients treated with placebo Because Xenical can interfere with the absorption of fat-soluble vitamins, all patients orlistat take a daily multivitamin that contains vitamins A, D, E, K, and beta-carotene.
The vitamin supplement should be taken at least 2 hours before or after Xenical [see Mechanism action and Administration 2Warnings and Precautions 5. Plasma concentrations of orlistat and its metabolites M1 and M3 were similar to those found in adults at the same dose level. Clinical studies of Xenical did not include sufficient numbers of patients aged 65 years and older to determine whether they action mechanism differently from younger patients [see Clinical Studies 14 ].
As with any weight-loss agent, the potential exists for abuse of Xenical in inappropriate patient populations e. See Indications and Usage 1 for recommended prescribing guidelines. Single doses of mg Xenical and multiple doses of up to mg three times a day for 15 days have been studied in normal weight and obese subjects without significant adverse findings. Should a significant overdose of Xenical occur, it is recommended that the patient be observed for 24 hours.
Based on human and animal studies, systemic effects attributable to the lipase-inhibiting properties of Xenical should be rapidly reversible. Xenical orlistat is a gastrointestinal lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats. Orlistat is S formylaminomethyl-pentanoic acid S [[ 2S, 3S hexyloxooxetanyl] methyl]-dodecyl ester.
Its empirical formula orlistat C 29 H 53 NO 5and its molecular weight is It is a single diastereomeric molecule that contains four chiral centers, with a negative optical rotation in ethanol at nm. Orlistat is a white to off-white crystalline powder. Orlistat is practically insoluble in water, freely soluble in mechanism, and very soluble in methanol and ethanol.
Orlistat has no p K a within the physiological pH range. Xenical is available for oral administration as orlistat turquoise hard-gelatin capsule. The capsule is imprinted with black. Each capsule contains a pellet formulation consisting of mg of the active ingredient, orlistat, as well as the inactive ingredients microcrystalline cellulose, sodium starch glycolate, sodium lauryl sulfate, povidone, and talc.
Orlistat is a reversible inhibitor of gastrointestinal lipases. It exerts its therapeutic activity in the lumen of the stomach and small intestine by forming a covalent bond with the active serine residue site of gastric and pancreatic lipases.
Comments:
Orlistat is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli [2] by GlaxoSmithKline in the United Kingdom and the United States.
Siegrid (taken for 2 to 7 years) 02.11.2017
41 users found this comment helpful.
Did you? Yes No | Report inappropriate
Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.
Kriemhild (taken for 3 to 7 years) 26.05.2018
41 users found this comment helpful.
Did you? Yes No | Report inappropriate
Send the page " " to a friend, relative, colleague or yourself. We do not record any personal information entered above.
Frank (taken for 3 to 4 years) 12.09.2016
35 users found this comment helpful.
Did you? Yes No | Report inappropriate
Gastric and pancreatic lipases are enzymes that play a pivotal role in the digestion of dietary fat. Orlistat, a semisynthetic derivative of lipstatin, is a potent and selective inhibitor of these enzymes, with little or no activity against amylase, trypsin, chymotrypsin and phospholipases. It exerts its effect within the gastrointestinal GI tract.
Winfried (taken for 2 to 4 years) 27.04.2016
22 users found this comment helpful.
Did you? Yes No | Report inappropriate